Global Parkinson's Disease Drug Market Outlook 2021

Publisher Name :
Date: 22-Dec-2020
No. of pages: 115
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Parkinson's Disease Drug market is segmented into

- Sinemet-CR

- Trastal

- Madopar

- COMT Inhibitor

- Other

Segment by Application

- Under 40 Years Old

- 40-65 Years Old

- Above 65 Years Old

Global Parkinson's Disease Drug Market: Regional Analysis

The Parkinson's Disease Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Parkinson's Disease Drug market report are:

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Parkinson's Disease Drug Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Parkinson's Disease Drug market include:

- Merck

- Akorn

- GSK

- Novartis

- Boehringer Ingelheim

- Teva Pharmaceutical

- Abbvie

- Kyowa Hakko Kirin Pharma

- Astellas Pharma

- Desitin Arzneimittel

- Endo Pharmaceuticals

- F.Hoffmann-La Roche

- H.Lundbeck

- Valeant

- Apokyn

- Orion

- Stada Arzneimittel

- US WorldMeds

- Bausch Health

Global Parkinson's Disease Drug Market Outlook 2021

Table of Contents
1 Parkinson's Disease Drug Market Overview
1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Parkinson's Disease Drug Segment by Type
1.2.1 Global Parkinson's Disease Drug Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Parkinson's Disease Drug Segment by Application
1.3.1 Parkinson's Disease Drug Sales Comparison by Application: (2020-2026)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson's Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Parkinson's Disease Drug Revenue 2015-2026
1.4.2 Global Parkinson's Disease Drug Sales 2015-2026
1.4.3 Parkinson's Disease Drug Market Size by Region: 2020 Versus 2026
2 Global Parkinson's Disease Drug Market Competition by Manufacturers
2.1 Global Parkinson's Disease Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Parkinson's Disease Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Parkinson's Disease Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Parkinson's Disease Drug Manufacturing Sites, Area Served, Product Type
2.5 Parkinson's Disease Drug Market Competitive Situation and Trends
2.5.1 Parkinson's Disease Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Parkinson's Disease Drug Players (Opinion Leaders)
3 Parkinson's Disease Drug Retrospective Market Scenario by Region
3.1 Global Parkinson's Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Parkinson's Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Parkinson's Disease Drug Market Facts & Figures by Country
3.3.1 North America Parkinson's Disease Drug Sales by Country
3.3.2 North America Parkinson's Disease Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Parkinson's Disease Drug Market Facts & Figures by Country
3.4.1 Europe Parkinson's Disease Drug Sales by Country
3.4.2 Europe Parkinson's Disease Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parkinson's Disease Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Parkinson's Disease Drug Sales by Region
3.5.2 Asia Pacific Parkinson's Disease Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parkinson's Disease Drug Market Facts & Figures by Country
3.6.1 Latin America Parkinson's Disease Drug Sales by Country
3.6.2 Latin America Parkinson's Disease Drug Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Parkinson's Disease Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Parkinson's Disease Drug Sales by Country
3.7.2 Middle East and Africa Parkinson's Disease Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Parkinson's Disease Drug Historic Market Analysis by Type
4.1 Global Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
4.2 Global Parkinson's Disease Drug Revenue Market Share by Type (2015-2020)
4.3 Global Parkinson's Disease Drug Price Market Share by Type (2015-2020)
4.4 Global Parkinson's Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Parkinson's Disease Drug Historic Market Analysis by Application
5.1 Global Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
5.2 Global Parkinson's Disease Drug Revenue Market Share by Application (2015-2020)
5.3 Global Parkinson's Disease Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Parkinson's Disease Drug Business
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview
6.1.3 Merck Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Akorn
6.2.1 Akorn Corporation Information
6.2.2 Akorn Description, Business Overview
6.2.3 Akorn Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Akorn Products Offered
6.2.5 Akorn Recent Development
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description, Business Overview
6.3.3 GSK Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GSK Products Offered
6.3.5 GSK Recent Development
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description, Business Overview
6.4.3 Novartis Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.4.5 Novartis Recent Development
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description, Business Overview
6.5.3 Boehringer Ingelheim Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Boehringer Ingelheim Products Offered
6.5.5 Boehringer Ingelheim Recent Development
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description, Business Overview
6.6.3 Teva Pharmaceutical Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Teva Pharmaceutical Products Offered
6.6.5 Teva Pharmaceutical Recent Development
6.7 Abbvie
6.6.1 Abbvie Corporation Information
6.6.2 Abbvie Description, Business Overview
6.6.3 Abbvie Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Abbvie Products Offered
6.7.5 Abbvie Recent Development
6.8 Kyowa Hakko Kirin Pharma
6.8.1 Kyowa Hakko Kirin Pharma Corporation Information
6.8.2 Kyowa Hakko Kirin Pharma Description, Business Overview
6.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Kyowa Hakko Kirin Pharma Products Offered
6.8.5 Kyowa Hakko Kirin Pharma Recent Development
6.9 Astellas Pharma
6.9.1 Astellas Pharma Corporation Information
6.9.2 Astellas Pharma Description, Business Overview
6.9.3 Astellas Pharma Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Astellas Pharma Products Offered
6.9.5 Astellas Pharma Recent Development
6.10 Desitin Arzneimittel
6.10.1 Desitin Arzneimittel Corporation Information
6.10.2 Desitin Arzneimittel Description, Business Overview
6.10.3 Desitin Arzneimittel Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Desitin Arzneimittel Products Offered
6.10.5 Desitin Arzneimittel Recent Development
6.11 Endo Pharmaceuticals
6.11.1 Endo Pharmaceuticals Corporation Information
6.11.2 Endo Pharmaceuticals Parkinson's Disease Drug Description, Business Overview
6.11.3 Endo Pharmaceuticals Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Endo Pharmaceuticals Products Offered
6.11.5 Endo Pharmaceuticals Recent Development
6.12 F.Hoffmann-La Roche
6.12.1 F.Hoffmann-La Roche Corporation Information
6.12.2 F.Hoffmann-La Roche Parkinson's Disease Drug Description, Business Overview
6.12.3 F.Hoffmann-La Roche Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 F.Hoffmann-La Roche Products Offered
6.12.5 F.Hoffmann-La Roche Recent Development
6.13 H.Lundbeck
6.13.1 H.Lundbeck Corporation Information
6.13.2 H.Lundbeck Parkinson's Disease Drug Description, Business Overview
6.13.3 H.Lundbeck Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 H.Lundbeck Products Offered
6.13.5 H.Lundbeck Recent Development
6.14 Valeant
6.14.1 Valeant Corporation Information
6.14.2 Valeant Parkinson's Disease Drug Description, Business Overview
6.14.3 Valeant Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Valeant Products Offered
6.14.5 Valeant Recent Development
6.15 Apokyn
6.15.1 Apokyn Corporation Information
6.15.2 Apokyn Parkinson's Disease Drug Description, Business Overview
6.15.3 Apokyn Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Apokyn Products Offered
6.15.5 Apokyn Recent Development
6.16 Orion
6.16.1 Orion Corporation Information
6.16.2 Orion Parkinson's Disease Drug Description, Business Overview
6.16.3 Orion Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Orion Products Offered
6.16.5 Orion Recent Development
6.17 Stada Arzneimittel
6.17.1 Stada Arzneimittel Corporation Information
6.17.2 Stada Arzneimittel Parkinson's Disease Drug Description, Business Overview
6.17.3 Stada Arzneimittel Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Stada Arzneimittel Products Offered
6.17.5 Stada Arzneimittel Recent Development
6.18 US WorldMeds
6.18.1 US WorldMeds Corporation Information
6.18.2 US WorldMeds Parkinson's Disease Drug Description, Business Overview
6.18.3 US WorldMeds Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.18.4 US WorldMeds Products Offered
6.18.5 US WorldMeds Recent Development
6.19 Bausch Health
6.19.1 Bausch Health Corporation Information
6.19.2 Bausch Health Parkinson's Disease Drug Description, Business Overview
6.19.3 Bausch Health Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Bausch Health Products Offered
6.19.5 Bausch Health Recent Development
7 Parkinson's Disease Drug Manufacturing Cost Analysis
7.1 Parkinson's Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parkinson's Disease Drug
7.4 Parkinson's Disease Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parkinson's Disease Drug Distributors List
8.3 Parkinson's Disease Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Parkinson's Disease Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parkinson's Disease Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Parkinson's Disease Drug by Type (2021-2026)
10.2 Parkinson's Disease Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parkinson's Disease Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Parkinson's Disease Drug by Application (2021-2026)
10.3 Parkinson's Disease Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parkinson's Disease Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Parkinson's Disease Drug by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease Drug Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Parkinson's Disease Drug Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Parkinson's Disease Drug Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Parkinson's Disease Drug Manufacturers Covered in This Study
Table 5. Global Parkinson's Disease Drug Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global Parkinson's Disease Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Parkinson's Disease Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Parkinson's Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Parkinson's Disease Drug Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Parkinson's Disease Drug Sales Sites and Area Served
Table 11. Manufacturers Parkinson's Disease Drug Product Types
Table 12. Global Parkinson's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Parkinson's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Parkinson's Disease Drug Players
Table 16. Global Parkinson's Disease Drug Sales (K Doses) by Region (2015-2020)
Table 17. Global Parkinson's Disease Drug Sales Market Share by Region (2015-2020)
Table 18. Global Parkinson's Disease Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Parkinson's Disease Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 21. North America Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 22. North America Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 25. Europe Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Parkinson's Disease Drug Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific Parkinson's Disease Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Parkinson's Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Parkinson's Disease Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 33. Latin America Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Parkinson's Disease Drug Sales (K Doses) by Type (2015-2020)
Table 41. Global Parkinson's Disease Drug Sales Share by Type (2015-2020)
Table 42. Global Parkinson's Disease Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Parkinson's Disease Drug Revenue Share by Type (2015-2020)
Table 44. Global Parkinson's Disease Drug Price (USD/Dose) by Type (2015-2020)
Table 45. Global Parkinson's Disease Drug Sales (K Doses) by Application (2015-2020)
Table 46. Global Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Table 47. Global Parkinson's Disease Drug Sales Growth Rate by Application (2015-2020)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Merck Main Product
Table 52. Merck Recent Development
Table 53. Akorn Corporation Information
Table 54. Akorn Description and Business Overview
Table 55. Akorn Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Akorn Main Product
Table 57. Akorn Recent Development
Table 58. GSK Corporation Information
Table 59. GSK Description and Business Overview
Table 60. GSK Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. GSK Main Product
Table 62. GSK Recent Development
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 66. Novartis Main Product
Table 67. Novartis Recent Development
Table 68. Boehringer Ingelheim Corporation Information
Table 69. Boehringer Ingelheim Description and Business Overview
Table 70. Boehringer Ingelheim Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 71. Boehringer Ingelheim Main Product
Table 72. Boehringer Ingelheim Recent Development
Table 73. Teva Pharmaceutical Corporation Information
Table 74. Teva Pharmaceutical Description and Business Overview
Table 75. Teva Pharmaceutical Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 76. Teva Pharmaceutical Main Product
Table 77. Teva Pharmaceutical Recent Development
Table 78. Abbvie Corporation Information
Table 79. Abbvie Description and Business Overview
Table 80. Abbvie Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. Abbvie Main Product
Table 82. Abbvie Recent Development
Table 83. Kyowa Hakko Kirin Pharma Corporation Information
Table 84. Kyowa Hakko Kirin Pharma Description and Business Overview
Table 85. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. Kyowa Hakko Kirin Pharma Main Product
Table 87. Kyowa Hakko Kirin Pharma Recent Development
Table 88. Astellas Pharma Corporation Information
Table 89. Astellas Pharma Description and Business Overview
Table 90. Astellas Pharma Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 91. Astellas Pharma Main Product
Table 92. Astellas Pharma Recent Development
Table 93. Desitin Arzneimittel Corporation Information
Table 94. Desitin Arzneimittel Description and Business Overview
Table 95. Desitin Arzneimittel Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 96. Desitin Arzneimittel Main Product
Table 97. Desitin Arzneimittel Recent Development
Table 98. Endo Pharmaceuticals Corporation Information
Table 99. Endo Pharmaceuticals Description and Business Overview
Table 100. Endo Pharmaceuticals Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 101. Endo Pharmaceuticals Main Product
Table 102. Endo Pharmaceuticals Recent Development
Table 103. F.Hoffmann-La Roche Corporation Information
Table 104. F.Hoffmann-La Roche Description and Business Overview
Table 105. F.Hoffmann-La Roche Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 106. F.Hoffmann-La Roche Main Product
Table 107. F.Hoffmann-La Roche Recent Development
Table 108. H.Lundbeck Corporation Information
Table 109. H.Lundbeck Description and Business Overview
Table 110. H.Lundbeck Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 111. H.Lundbeck Main Product
Table 112. H.Lundbeck Recent Development
Table 113. Valeant Corporation Information
Table 114. Valeant Description and Business Overview
Table 115. Valeant Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. Valeant Main Product
Table 117. Valeant Recent Development
Table 118. Apokyn Corporation Information
Table 119. Apokyn Description and Business Overview
Table 120. Apokyn Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 121. Apokyn Main Product
Table 122. Apokyn Recent Development
Table 123. Orion Corporation Information
Table 124. Orion Description and Business Overview
Table 125. Orion Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 126. Orion Main Product
Table 127. Orion Recent Development
Table 128. Stada Arzneimittel Corporation Information
Table 129. Stada Arzneimittel Description and Business Overview
Table 130. Stada Arzneimittel Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 131. Stada Arzneimittel Main Product
Table 132. Stada Arzneimittel Recent Development
Table 133. US WorldMeds Corporation Information
Table 134. US WorldMeds Description and Business Overview
Table 135. US WorldMeds Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 136. US WorldMeds Main Product
Table 137. US WorldMeds Recent Development
Table 138. Bausch Health Corporation Information
Table 139. Bausch Health Description and Business Overview
Table 140. Bausch Health Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 141. Bausch Health Main Product
Table 142. Bausch Health Recent Development
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Parkinson's Disease Drug Distributors List
Table 146. Parkinson's Disease Drug Customers List
Table 147. Parkinson's Disease Drug Market Trends
Table 148. Parkinson's Disease Drug Opportunities and Drivers
Table 149. Parkinson's Disease Drug Market Challenges
Table 150. Global Parkinson's Disease Drug Sales (K Doses) Forecast by Type (2021-2026)
Table 151. Global Parkinson's Disease Drug Sales Market Share Forecast by Type (2021-2026)
Table 152. Global Parkinson's Disease Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 153. Global Parkinson's Disease Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 154. Global Parkinson's Disease Drug Sales (K Doses) Forecast by Application (2021-2026)
Table 155. Global Parkinson's Disease Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 156. Global Parkinson's Disease Drug Sales (K Doses) Forecast by Region (2021-2026)
Table 157. Global Parkinson's Disease Drug Sales Market Share Forecast by Region (2021-2026)
Table 158. Global Parkinson's Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Global Parkinson's Disease Drug Revenue Market Share Forecast by Region (2021-2026)
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Parkinson's Disease Drug
Figure 2. Global Parkinson's Disease Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Sinemet-CR Product Picture
Figure 4. Trastal Product Picture
Figure 5. Madopar Product Picture
Figure 6. COMT Inhibitor Product Picture
Figure 7. Other Product Picture
Figure 8. Global Parkinson's Disease Drug Consumption Market Share by Application: 2020 VS 2026
Figure 9. Under 40 Years Old
Figure 10. 40-65 Years Old
Figure 11. Above 65 Years Old
Figure 12. Global Parkinson's Disease Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Parkinson's Disease Drug Sales Capacity (K Doses) (2015-2026)
Figure 14. Global Parkinson's Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Parkinson's Disease Drug Sales Share by Manufacturers in 2020
Figure 16. Global Parkinson's Disease Drug Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease Drug Revenue in 2019
Figure 18. Parkinson's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Parkinson's Disease Drug Sales Market Share by Region (2015-2020)
Figure 20. Global Parkinson's Disease Drug Sales Market Share by Region in 2019
Figure 21. Global Parkinson's Disease Drug Revenue Market Share by Region (2015-2020)
Figure 22. Global Parkinson's Disease Drug Revenue Market Share by Region in 2019
Figure 23. North America Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 24. North America Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 25. U.S. Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 26. U.S. Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 28. Canada Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 30. Europe Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 31. Germany Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 32. Germany Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 34. France Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 36. U.K. Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Italy Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 40. Russia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Parkinson's Disease Drug Sales Market Share by Region in 2019
Figure 42. Asia Pacific Parkinson's Disease Drug Revenue Market Share by Region in 2019
Figure 43. China Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 44. China Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 46. Japan Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 48. South Korea Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 50. India Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Australia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 54. Taiwan Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 56. Indonesia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 58. Thailand Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 60. Malaysia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 62. Philippines Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 64. Vietnam Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 66. Latin America Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 67. Mexico Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Mexico Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Brazil Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Argentina Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 75. Turkey Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Turkey Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Saudi Arabia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 80. U.A.E Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Parkinson's Disease Drug by Type (2015-2020)
Figure 82. Sales Market Share of Parkinson's Disease Drug by Type in 2020
Figure 83. Global Parkinson's Disease Drug Market Share by Price Range (2015-2020)
Figure 84. Revenue Market Share of Parkinson's Disease Drug by Type in 2019
Figure 85. Global Parkinson's Disease Drug Sales Growth by Type (2015-2020) (K Doses)
Figure 86. Sales Market Share of Parkinson's Disease Drug by Application (2015-2020)
Figure 87. Sales Market Share of Parkinson's Disease Drug by Application in 2020
Figure 88. Revenue Share of Parkinson's Disease Drug by Application (2015-2020)
Figure 89. Revenue Share of Parkinson's Disease Drug by Application in 2020
Figure 90. Key Raw Materials Price Trend
Figure 91. Manufacturing Cost Structure of Parkinson's Disease Drug
Figure 92. Manufacturing Process Analysis of Parkinson's Disease Drug
Figure 93. Parkinson's Disease Drug Industrial Chain Analysis
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Porter's Five Forces Analysis
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
  • Global Parkinsons disease Drug Market Research Report 2021
    Published: 31-Mar-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Carbidopa/Levodopa - Dopamine Receptor Agonists - MAO-Inhibitors Segment by Application......
  • Global Rasagiline Tablet Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 28-Mar-2021        Price: US 2980 Onwards        Pages: 89
    Snapshot The global Rasagiline Tablet market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Rasagiline Tablet by product, region and application, in addition, this report introduces market competition situation among the vendors and company pr......
  • Global Parkinson's Disease Drug Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 25-Feb-2021        Price: US 2980 Onwards        Pages: 108
    Snapshot The global Parkinson's Disease Drug market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Parkinson's Disease Drug by product, region and application, in addition, this report introduces market competition situation among the vendors ......
  • Parkinson's Disease Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
    Published: 31-Jan-2021        Price: US 3000 Onwards        Pages: 118
    Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by......
  • Global Parkinson's Disease (PD) Drugs Market Research Report 2021
    Published: 29-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Dopamine Agonist - Monoamine Oxidase Inhibitors - Acetylcholinesterase Inhibitors - Glutamate Inhibi......
  • Global Rasagiline Tablet Market Research Report 2021
    Published: 25-Jan-2021        Price: US 2900 Onwards        Pages: 123
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 0.5 mg/Pcs - 1 mg/Pcs Segment by Application - Under 40 Years Old - 40-65 Years Old......
  • Global Parkinson's Disease Therapeutics Professional Survey Report 2021, Forecast to 2026
    Published: 14-Jan-2021        Price: US 3280 Onwards        Pages: 131
    The report forecast global Parkinson's Disease Therapeutics market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively." The report demonstrates detail coverage of P......
  • Global Parkinson's Disease Therapeutics Market Research Report 2021, Forecast to 2026
    Published: 14-Jan-2021        Price: US 2680 Onwards        Pages: 162
    The report forecast global Parkinson's Disease Therapeutics market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively." The report demonstrates detail coverage of P......
  • Global Parkinson's Disease (PD) Drugs Market Outlook 2021
    Published: 24-Dec-2020        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Parkinson's Disease (PD) Drugs market is segmented into - Dopamine Agonist - Monoamine Oxidase Inhibitors......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs